The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants

References

• Abubakar, A., Holding, P., Newton, C. R. J. C., Van Baar, A., & Van de Vijver, F. J. R. (2009). The role of weight for age and disease stage in poor psychomotor outcome of HIV-infected children in Kilifi, Kenya. Developmental Medicine and Child Neurology, 51, 968–973. doi:10.1111/j.1469-8749.2009.03333.x
   PubMed Web of Science ®Google Scholar
• Armstrong, F. D., Seidel, J. F., & Swales, T. P. (1993). Pediatric HIV infection: A Neuropsychological and educational challenge. Journal of Learning Disabilities, 26(2), 92–103. doi:10.1177/002221949302600202
   PubMed Web of Science ®Google Scholar
• Baillieu, N., & Potterton, J. (2008). The extent of delay of language, motor and cognitive development in HIV-Positive infants. Journal of Neurologic Physical Therapy, 32(3), 118–121. doi:10.1097/NPT.0b013e3181846232
   PubMedGoogle Scholar
• Bayley, N. (2006). Bayley scales of infant development (3rd ed.). San Antonia, TX: The Psychological Corporation.
   Google Scholar
• Blanchette, N., Smith, M. L., Fernandes-Penney, A., King, S., & Read, S. (2001). Cognitive and motor development in children with vertically transmitted HIV infection. Brain and Cognition, 46(1–2), 50–53. doi:10.1016/S0278-2626(01)80032-4
   PubMed Web of Science ®Google Scholar
• Boivin, M. J., Green, S. D. R., Davies, A. G., Giordani, B., Mokili, J. K. L., & Cutting, W. A. M. (1995). A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian Children. Health Psychology, 14(1), 13–21. doi:10.1037/0278-6133.14.1.13
   PubMed Web of Science ®Google Scholar
• Bracher, L., Valerius, N. H., Rosenfeldt, V., Herlin, T., Fisker, N., Nielsen, H., … Obel, N. (2007). Long term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark. Scandinavian Journal of Infectious Diseases, 39, 799–804. doi:10.1080/00365540701203493
   PubMed Web of Science ®Google Scholar
• Brackis-Cott, E., Kang, E., Dolezal, C., Abrams, E. J., & Mellins, C. A. (2009). The impact of perinatal HIV infection on older school-aged children's and adolescents' receptive language and word recognition skills. Aids Patient Care and STDs, 23, 415–421. doi:10.1089/apc.2008.0197
   PubMed Web of Science ®Google Scholar
• Bruck, I., Tahan, T. T., da Cruz, C. R., Martins, L. T. F., Antoniuk, S. A., Rodrigues, M., … de Bruyn, L. R. (2001). Developmental milestones of vertically HIV infected and serorevertors children. Arquivos de Neuro-Psiquiatria, 59, 691–695. doi:10.1590/S0004-282X2001000500007
   PubMed Web of Science ®Google Scholar
• Buonora, S., Nogueira, S., Pone, M. V., Aloé, M., Oliveira, R. H., & Hofer, C. (2008). Growth Parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil. Annals of Tropical Paediatrics, 28(1), 59–64. doi:10.1179/146532808X270699
   PubMed Web of Science ®Google Scholar
• Burns, S., Hernandez-Reif, M., & Jessee, P. (2008). A review of pediatric HIV effects on neurocognitive development. Issues in Comprehensive Pediatric Nursing, 31(3), 107–121. doi:10.1080/01460860802272870
   PubMedGoogle Scholar
• Chase, C., Vibbert, M., Pelton, S. I., Coulter, D. L., & Cabral, H. (1995). Early neurodevelopmental growth in children with vertically transmitted human immunodeficiency virus infection. Archives of Pediatrics and Adolescent Medicine, 149, 850–855 doi:10.1001/archpedi.1995.02170210024004
   PubMed Web of Science ®Google Scholar
• Chiappini, E., Galli, L., Tovo, P.-A., Gabiano, C., Lisi, C., Gattinara, G. C., … de Martino, M. (2007). Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS, 21, 1607–1615. doi:10.1097/QAD.0b013e32823ecf5b
   PubMed Web of Science ®Google Scholar
• Chiriboga, C. A., Fleishman, S., Champion, S., Gaye-Robinson, L., & Abrams, E. J. (2005). Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy. Journal of Pediatrics, 146, 402–407. doi:10.1016/j.jpeds.2004.10.021
   PubMed Web of Science ®Google Scholar
• Coplan, J., Contello, K. A., Cunningham, C. K., Weiner, L. B., Dye, T. D., Roberge, L., … Kirkwood, K. (1998). Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics, 102, e8. Retrieved from http://www.pediatrics.org/cgi/content/full/102/1/e8 10.1542/peds.102.1.e8
   PubMed Web of Science ®Google Scholar
• Drotar, D., Olness, K., Wiznitzer, M., Guay, L., Marum, L., Svilar, G., … Kiziri-Mayengo, R., (1997). Neurodevelopment outcomes of ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics, 100, e5. doi:10.1542/peds.100.1.e5
   PubMed Web of Science ®Google Scholar
• Engle, P. L., Fernald, L. C. H., Alderman, H., Behrman, J., O'Gara, C., Yousafzai, A., … Iltus, S. (2011). Strategies for reducing inequalities and improving developmental outcomes for young children in low income and middle income countries. The Lancet, 378, 1339–1353. doi:10.1016/S0140-6736(11)60889-1
   PubMed Web of Science ®Google Scholar
• Epstein, L. G., & Gelbard, H. A. (1999). HIV-1 Induced neuronal injury in the developing brain. Journal of Leukocyte Biology, 65, 453–457.
   PubMed Web of Science ®Google Scholar
• Ferguson, G., & Jelsma, J. (2009). The prevalence of motor delay among HIV infected children living Cape Town, South Africa. International Journal of Rehabilitation Research, 32(2), 108–114. doi:10.1097/MRR.0b013e3283013b34
   PubMed Web of Science ®Google Scholar
• Foster, C. J., Biggs, R. L., Melvin, D., Walters, M. D. S., Tudor-Williams, G., & Lyall, E. G. H. (2006). Neurodevelopmental outcomes in children with HIV Infection under 3 years of age. Developmental Medicine and Child Neurology, 48, 677–682. doi:10.1017/S0012162206001423
   PubMed Web of Science ®Google Scholar
• Gay, C. L., Armstrong, F. D., Cohen, D., Lain, S., Hardy, M. D., Swales, T. P., … Scott, G. B. (1995). The effects of HIV in cognitive and motor development in children born to HIV-Seropositive women with no reported drug use: Birth to 24 months. Pediatrics, 96, 1078–1082.
   PubMed Web of Science ®Google Scholar
• Guillén, S., Ramos, J. T., Resino, R., Bellón, J. M., & Muñoz, M. A. (2007). Impact on weight and height with the use of HAART in HIV-Infected children. The Pediatric Infectious Disease Journal, 26, 334–338. doi:10.1097/01.inf.0000257427.19764.ff
   PubMed Web of Science ®Google Scholar
• Herbert, R., Janvedt, G., Mead, J., & Hagem, K. (2005). Practical Evidence based Physiotherapy. London: Elsevier Butterworth Heineman.
   Google Scholar
• Janssens, B., Raleigh, B., Soeung, S., Akao, K., Te, V., Gupta, J., … Nerrienet, E. (2007). Effectiveness of highly active antiretroviral therapy in HIV positive children: Evaluation at 12 months in a routine program in Cambodia. Pediatrics, 120, e1134–e1140. doi:10.1542/peds.2006-3503
   PubMed Web of Science ®Google Scholar
• Jeremy, R. J., Kim, S., Nozyce, M., Nachman, S., McIntosh, K., Pelton, S. I., … Stanley, K. (2005). Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-Infected children. Pediatrics, 115, 380–387. doi:10.1542/peds.2004-1108
   PubMed Web of Science ®Google Scholar
• Jones, S. A., Sherman, G. G., & Varga, C. A. (2005). Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. AIDS Care, 17, 466–470. doi:10.1080/09540120412331319723
   PubMed Web of Science ®Google Scholar
• Lindsey, J. C., Malee, K. M., Brouwers, P., & Hughes, M. D. (2007). Neurodevelopmental functioning in HIV –Infected infants and young children before and after the introduction of protease inhibitor – Based highly active antiretroviral therapy. Pediatrics, 119, e681–e693. Retrieved from http://pediatrics.aappublications.org/content/119/3/e681.full.html doi:10.1542/peds.2006-1145
   PubMed Web of Science ®Google Scholar
• Lyman, W. D., Kress, Y., Kure, K., Rashbaum, W. K., Rubinstein, A., & Soeiro, R. (1990). Detection of HIV in fetal central nervous system tissue. AIDS, 4, 917–920. doi:10.1097/00002030-199009000-00014
   PubMed Web of Science ®Google Scholar
• McCoig, C., Castrejón, M. M., Castaño, E., de Suman, O., Báez, C., Redondo, W., … Ramilo, O. (2002). Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV Resistance, and clinical manifestations of encephalopathy. The Journal of Pediatrics, 141(1), 36–44. doi:10.1067/mpd.2002.125007
   PubMed Web of Science ®Google Scholar
• McGrath, N., Fawzi, W. W., Bellinger, D., Robins, J., Msamanga, G. I., Manji, K., … Tronick, E. (2006). The timing of mother-to-child transmission of human immunodeficiency virus infection and the neurodevelopment of children in Tanzania. The Pediatric Infectious Disease Journal, 25(1), 47–52. doi:10.1097/01.inf.0000195638.80578.e0
   PubMed Web of Science ®Google Scholar
• Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., … Cooper, C. (2006). Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine, 3, 2039–2063.
   Web of Science ®Google Scholar
• Nesheim, S. R., Kapogiannis, B. G., Soe, M. M., Sullivan, K. M., Abrams, E., Farley, J., … Bulterys, M. (2007). Trends in opportunistic infections in the pre- and post – highly active antiretroviral therapy eras among HIV infected children in the Perinatal AIDS Collaborative Transmission Study, 1986 – 2004. Pediatrics, 120, 100–109. doi:10.1542/peds.2006-2052
   PubMed Web of Science ®Google Scholar
• Newell, M.-L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., & Dabis, F. (2004). Mortality of infected and uninfected infants born to HIV Infected mothers in Africa: A pooled analysis. The Lancet, 364, 1236–1243. doi:10.1016/S0140-6736(04)17140-7
   PubMed Web of Science ®Google Scholar
• Nozyce, M., Hittelman, J., Muenz, L., Durako, S. J., Fischer, M. L., & Willoughby, A. (1994). Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics, 94, 883–891.
   PubMed Web of Science ®Google Scholar
• Patel, K., Ming, X., Williams, P. L., Robertson, K. R., Oleske, J. M., & Seage, G. R. (2009). Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS, 23, 1893–1901. doi:10.1097/QAD.0b013e32832dc041
   PubMed Web of Science ®Google Scholar
• Pearson, D. A., McGrath, N. M., Nozyce, M., Nichols, S. L., Raskino, C., Brouwers, P., … Englund, J. A. (2000). Predicting HIV disease progression in children using measures of neuropsychological and neuroradiological functioning. Pediatrics, 106(6), 1–10. Retrieved from http://www.pediatrics.org/cgi/cpntent/full/106/6/e76 doi:10.1542/peds.106.6.e76
   PubMed Web of Science ®Google Scholar
• Pollack, H., Kuchuk, A., Cowan, L. M., Hacimamutoglu, S., Glasberg, H., David, R., … Oberfield, S. (1996). Neurodevelopment, growth and viral load in HIV-Infected infants. Brain, Behavior and Immunity, 10, 298–312. doi:10.1006/brbi.1996.0026
   PubMed Web of Science ®Google Scholar
• Potterton, J. L., & Eales, C. J. (2001) Prevalence of developmental delay in infants who are HIV positive. South African Journal of Physiotherapy, 57, 11–15.
   Google Scholar
• Potterton, J., Stewart, A., Cooper, P., & Becker, P. (2009). The effect of a basic home stimulation programme on the development of young children infected with HIV. Developmental Medicine and Child Neurology, 106(6), 1–10. Retrieved from http://dx.doi.org/10.1111/j.1469-8749.2009.03534.x.
   Google Scholar
• Potterton, J., Stewart, A., Cooper, P., Goldberg, L., Gajdosik, C., & Baillieu, N. (2009). Neurodevelopmental delay in children infected with human immunodeficiency virus in Soweto, South Africa. Vulnerable Children and Youth Studies, 4(1), 48–57. doi:10.1080/17450120802183728
   Google Scholar
• Raskino, C., Pearson, D. A., Baker, C. J., Lifschitz, M. H., O'Donnell, K., Mintz, M., … Englund, J. A. (1999). Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics, 104(3), e32–e32. doi:10.1542/peds.104.3.e32
   Google Scholar
• Resino, S., Resino, R., Micheloud, D., Gurbindo-Gutierrez, D., Leon, J. A., Ramos, J. T., … Munoz-Fernandez, A. (2006). Long term effects of highly active antiretroviral therapy in pretreated, vertically HIV Type 1 – infected children: 6 years of follow-up. Clinical Infectious Diseases, 42(6), 862–869. doi:10.1086/500412
   PubMed Web of Science ®Google Scholar
• Rosen, S., Fox, M. P., & Gill, C. J. (2007). Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: A systematic review. PLoS Medicine, 4, 1691–1701.
   Web of Science ®Google Scholar
• Sánchez-Ramón, S., Resino, S., Bellón Cano, J. M., Ramos, J. T., Gurbindo, D., & Muñoz-Fernández, A. (2003). Neuroprotective effects of early antiretrovirals in vertical HIV infection. Pediatric Neurology, 29(3), 218–221. doi:10.1016/S0887-8994(03)00210-8
   PubMed Web of Science ®Google Scholar
• Schulz, K. F., Altman, D. G., & Moher, D. (2010). Consort 2010 statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine, 152(11), 726–732. doi:10.7326/0003-4819-152-11-201006010-00232
   PubMed Web of Science ®Google Scholar
• Song, R., Jelagat, J., Dzombo, D., Mwalimu, M., Mandaliya, K., Shikely, K., … Essajee, S. (2007). Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Pediatrics, 120, e8256–e8861. Retrieved from http://www.pediatrics.org/cgi/content/full/120/4/e856
   Google Scholar
• South Africa. (2010). Country Progress Report of the declaration of commitment on HIV/AIDS 2010 Report. Johannesburg: Department of Health.
   Google Scholar
• Tahan, T. T., Bruck, I., Burger, M., & Cruz, C. R. (2006). Neurological profile and neurodevelopment of 85 children infected with HIV and 84 Seroreverter children followed from 1995 to 2002. The Brazilian Journal of Infectious Diseases, 10(5), 322–326. doi:10.1590/S1413-86702006000500004
   PubMedGoogle Scholar
• UNAIDS. (2011). World AIDS Day Report 2011: How to get to zero faster. Author. Retrieved from www.unaids.org.en/media/unaids/contentassets/documents/epidemiology/2011/gr2011/JC2434_worldAIDSday_results_en.pdf
   Google Scholar
• Van Rie, A., Dow, A., Mupuala, A., & Stewart, P. (2009). Neurodevelopment trajectory of HIV-Infected children accessing care in Kinshasa, Democratic Republic of Congo. Journal of Acquired Immune Deficiency Syndromes, 52(5), 636–642. doi:10.1097/QAI.0b013e3181b32646
   PubMed Web of Science ®Google Scholar
• Van Rie, A., Harrington, P. R., Dow, A., & Robertson, K. (2007). Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective. European Journal of Paediatric Neurology, 11(1), 1–9. doi:10.1016/j.ejpn.2006.10.006
   PubMed Web of Science ®Google Scholar
• Van Rie, A., Mupuala, A., & Dow, A. (2008). Impact of the HIV/AIDS Epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics, 122(1), e123–e128. doi:10.1542/peds.2007-2558
   PubMed Web of Science ®Google Scholar
• Violari, A., Cotton, M. F., Gibb, D. M., Babiker, A. G., Steyn, J., Madhi, S. A., … McIntyre, J. A. (2008). Early antiretroviral therapy and mortality among HIV-Infected infants. The New England Journal of Medicine, 359(21), 2233–2244. doi:10.1056/NEJMoa0800971
   PubMed Web of Science ®Google Scholar
• Wolters, P. L., Brouwers, P., Civitello, L., & Moss, H. A. (1997). Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24 – month follow –up study. AIDS, 11, 1135–1144. doi:10.1097/00002030-199709000-00009
   PubMed Web of Science ®Google Scholar